171 related articles for article (PubMed ID: 29118813)
1. The Leukemic Stem Cell Niche: Adaptation to "Hypoxia" versus Oncogene Addiction.
Cheloni G; Poteti M; Bono S; Masala E; Mazure NM; Rovida E; Lulli M; Dello Sbarba P
Stem Cells Int; 2017; 2017():4979474. PubMed ID: 29118813
[TBL] [Abstract][Full Text] [Related]
2. Tissue "Hypoxia" and the Maintenance of Leukemia Stem Cells.
Dello Sbarba P; Cheloni G
Adv Exp Med Biol; 2019; 1143():129-145. PubMed ID: 31338818
[TBL] [Abstract][Full Text] [Related]
3. One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a "hypoxic" environment.
Rovida E; Marzi I; Cipolleschi MG; Dello Sbarba P
Hypoxia (Auckl); 2014; 2():1-10. PubMed ID: 27774462
[TBL] [Abstract][Full Text] [Related]
4. Chronic Myeloid Leukemia and Hepatoblastoma: Two Cancer Models to Link Metabolism to Stem Cells.
Cipolleschi MG; Marzi I; Rovida E; Dello Sbarba P
Front Oncol; 2016; 6():95. PubMed ID: 27148487
[TBL] [Abstract][Full Text] [Related]
5. Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell Maintenance.
Ly M; Rentas S; Vujovic A; Wong N; Moreira S; Xu J; Holzapfel N; Bhatia S; Tran D; Minden MD; Draper JS; Hope KJ
Cancer Res; 2019 Nov; 79(22):5799-5811. PubMed ID: 31519687
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia regulates the hematopoietic stem cell niche.
Morikawa T; Takubo K
Pflugers Arch; 2016 Jan; 468(1):13-22. PubMed ID: 26490456
[TBL] [Abstract][Full Text] [Related]
7. Novel therapeutic strategies to target leukemic cells that hijack compartmentalized continuous hematopoietic stem cell niches.
Hira VVV; Van Noorden CJF; Carraway HE; Maciejewski JP; Molenaar RJ
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):183-198. PubMed ID: 28363872
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic Stem Cells: Normal Versus Malignant.
Carroll D; St Clair DK
Antioxid Redox Signal; 2018 Dec; 29(16):1612-1632. PubMed ID: 29084438
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA HOTAIR promotes the self-renewal of leukemia stem cells through epigenetic silencing of p15.
Gao S; Zhou B; Li H; Huang X; Wu Y; Xing C; Yu X; Ji Y
Exp Hematol; 2018 Nov; 67():32-40.e3. PubMed ID: 30172749
[TBL] [Abstract][Full Text] [Related]
10. Leukemic progenitor cells are susceptible to targeting by stimulated cytotoxic T cells against immunogenic leukemia-associated antigens.
Schneider V; Zhang L; Rojewski M; Fekete N; Schrezenmeier H; Erle A; Bullinger L; Hofmann S; Götz M; Döhner K; Ihme S; Döhner H; Buske C; Feuring-Buske M; Greiner J
Int J Cancer; 2015 Nov; 137(9):2083-92. PubMed ID: 25912930
[TBL] [Abstract][Full Text] [Related]
11. Loss of quiescence and self-renewal capacity of hematopoietic stem cell in an in vitro leukemic niche.
Vanegas NP; Vernot JP
Exp Hematol Oncol; 2017; 6():2. PubMed ID: 28078190
[TBL] [Abstract][Full Text] [Related]
12. Influence of Bone Marrow Microenvironment on Leukemic Stem Cells: Breaking Up an Intimate Relationship.
Agarwal P; Bhatia R
Adv Cancer Res; 2015; 127():227-52. PubMed ID: 26093902
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress and hypoxia in normal and leukemic stem cells.
Testa U; Labbaye C; Castelli G; Pelosi E
Exp Hematol; 2016 Jul; 44(7):540-60. PubMed ID: 27179622
[TBL] [Abstract][Full Text] [Related]
14. Limbal stem cells: identity, developmental origin, and therapeutic potential.
Gonzalez G; Sasamoto Y; Ksander BR; Frank MH; Frank NY
Wiley Interdiscip Rev Dev Biol; 2018 Mar; 7(2):. PubMed ID: 29105366
[TBL] [Abstract][Full Text] [Related]
15. Amide-linked local anesthetics preferentially target leukemia stem cell through inhibition of Wnt/β-catenin.
Ni J; Xie T; Xiao M; Xiang W; Wang L
Biochem Biophys Res Commun; 2018 Sep; 503(2):956-962. PubMed ID: 29932919
[TBL] [Abstract][Full Text] [Related]
16. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang.
Zhou HS; Carter BZ; Andreeff M
Cancer Biol Med; 2016 Jun; 13(2):248-59. PubMed ID: 27458532
[TBL] [Abstract][Full Text] [Related]
18. Severe hypoxia defines heterogeneity and selects highly immature progenitors within clonal erythroleukemia cells.
Giuntoli S; Rovida E; Gozzini A; Barbetti V; Cipolleschi MG; Olivotto M; Dello Sbarba P
Stem Cells; 2007 May; 25(5):1119-25. PubMed ID: 17255519
[TBL] [Abstract][Full Text] [Related]
19. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
Al-Mawali A; Gillis D; Lewis I
J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cells in hematological disorders: current and possible new therapeutic approaches.
Annaloro C; Onida F; Saporiti G; Lambertenghi Deliliers G
Curr Pharm Biotechnol; 2011 Feb; 12(2):217-25. PubMed ID: 21044004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
